Stroke

December 7, 2017

Natural product-derived therapy for Stroke: Huperzine A attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/December/2017, 8.43 am

Natural product-derived therapy for Stroke: Huperzine A attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/December/2017, 8.43 am https://genomediscovery.org/wp-content/uploads/2017/12/Huperzine-A-functions-as-an-antistroke-agent-through-induction-of-BDNF-and-NAMPT.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/12/Huperzine-A-functions-as-an-antistroke-agent-through-induction-of-BDNF-and-NAMPT.jpg2_.jpg December 7, 2017 December 7, 2017

Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; and School of Public…

December 3, 2017

Natural product-derived therapy for Stroke: Eucalyptol, isolated from Eucalyptus globulus, Cinnamomum camphora, Bay leaves, and Rosemary, among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 3/December/2017, 10.03 pm

Natural product-derived therapy for Stroke: Eucalyptol, isolated from Eucalyptus globulus, Cinnamomum camphora, Bay leaves, and Rosemary, among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 3/December/2017, 10.03 pm https://genomediscovery.org/wp-content/uploads/2017/12/A-therapeutic-mix-encompassing-Eucalyptol1-8-Cineol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/12/A-therapeutic-mix-encompassing-Eucalyptol1-8-Cineol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg December 3, 2017 December 3, 2017

December 1, 2017

Molecular therapy for Stroke: Cilostazol, a phosphodiesterase inhibitor used in the treatment of Perpheral vascular disease, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 1/December/2017, 6.44 pm

Molecular therapy for Stroke: Cilostazol, a phosphodiesterase inhibitor used in the treatment of Perpheral vascular disease, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 1/December/2017, 6.44 pm https://genomediscovery.org/wp-content/uploads/2017/12/Cilostazol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/12/Cilostazol-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT2.jpg December 1, 2017 December 1, 2017

November 24, 2017

Natural product-derived therapy for Stroke: Safranal, isolated from Saffron, Rooibos and among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 24/November/2017, 8.14 am

Natural product-derived therapy for Stroke: Safranal, isolated from Saffron, Rooibos and among others, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 24/November/2017, 8.14 am https://genomediscovery.org/wp-content/uploads/2017/11/Safranal-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Safranal-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg2_.jpg November 24, 2017 November 24, 2017

November 17, 2017

Molecular therapy for Stroke: Butylphthalide (3-n-butylphthalide or NBP), found in celery oil, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 17/November/2017, 5.54 am

Molecular therapy for Stroke: Butylphthalide (3-n-butylphthalide or NBP), found in celery oil, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 17/November/2017, 5.54 am https://genomediscovery.org/wp-content/uploads/2017/11/DL-3-n-Butylphthalide-NBP-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/DL-3-n-Butylphthalide-NBP-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT1.jpg November 17, 2017 November 17, 2017

November 7, 2017

Molecular therapy for Stroke: A therapeutic mix encompassing docosahexaenoic acid (DHA) and aspirin (ASA) [DHAASA] attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/November/2017, 11.43 pm

Molecular therapy for Stroke: A therapeutic mix encompassing docosahexaenoic acid (DHA) and aspirin (ASA) [DHAASA] attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/November/2017, 11.43 pm https://genomediscovery.org/wp-content/uploads/2017/11/DHAASA-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/DHAASA-acts-as-an-anti-stroke-agent-by-increasing-the-expression-of-BDNF-and-NAMPT.jpg2_.jpg November 7, 2017 November 7, 2017

Natural product-derived therapy for Stroke: Huperzine A attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/December/2017, 8.43 am

Popular Post